Skip to main content
Caplight Logo









Galtec

Galtec

Private
Buenos AiresHealthcare & Life Scienceshttps://galtec.ar/

Last Round

Seed

Dec 15, 2023

Company Overview

Galtec is a biotechnology company that develops immunotherapies based on the modulation of galectins for the treatment of cancer, autoimmune diseases, and chronic inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyimmunotherapydrug discoverymonoclonal antibodiesglycobiologycancer therapyautoimmune disease treatmentbiotech startupgalectin-1glycocheckpointsbiopharmapreclinical developmenttherapeutic candidatespatent licensingdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galtec Comparables

Compare Galtec with similar companies based on industry and business-model similarity.

Galtec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valora Therapeutics Inc.
85%
GlycoTherapeutics
80%
Palleon Pharmaceuticals
76%

Galtec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 15, 2023

Key People

Founding team and executive leadership

Daniel Falcón

Co Founder and CEO

Founding Team

Galtec Investors

Notable investors and investment history

Galtec investors
InvestorRounds
White LionsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 34% MoM.

  • Jan 7, 2026

    Monthly visitors increased 136% MoM, reaching 1.4K.

Galtec Filings

Explore SEC and related filing metadata, where available.

Galtec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Galtec's valuation, stock price, and market status.

Is Galtec a public or private company?

Galtec is a private company.

What is the current stock price of Galtec?

Galtec is a private company with no public stock price. No recent secondary market data is available.

How much is Galtec worth (valuation)?

Valuation information for Galtec is not publicly available.

Can I buy Galtec stock?

Galtec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Galtec's last funding round?

Galtec's most recent funding round was Seed on December 15, 2023.

Who are the main investors in Galtec?

Key investors in Galtec include White Lions.

Will Galtec IPO soon?

No public IPO plans have been announced for Galtec.

How can I track Galtec secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Galtec's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBuenos Aires
Employee Range13
Year Founded2023
Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?